Quantcast

Latest University of Texas Stories

2012-06-22 16:08:18

Protein binds to growth factor receptor, priming it for normal function; Likely tie to 4 cancers Once considered merely a passive link between proteins that matter, Grb2 - pronounced "grab2" - actually lives up to its nickname with its controlling grip on an important cell signaling pathway, scientists at The University of Texas MD Anderson Cancer Center report in the June 22 issue of Cell. "Grb2 is a switch that controls normal signaling through the fibroblast growth factor receptor...

2012-05-18 23:51:29

3-pronged study reveals high response rate in other advanced melanoma patients and activity in multiple cancers An experimental drug targeting a common mutation in melanoma successfully shrank tumors that spread to the brain in nine out of 10 patients in part of an international phase I clinical trial report in the May 18 issue of The Lancet. The drug dabrafenib, which targets the Val600 BRAF mutation that is active in half of melanoma cases, also cut the size of tumors in 25 of 36...

2012-05-18 01:51:35

Novel adjuvant therapy shows promise for women with a history of breast cancer in Phase II clinical trial A breast cancer vaccine already shown to elicit a powerful immune response in women with varying levels of HER2 expression has the ability to improve recurrence rates and is well tolerated in an adjuvant setting, according to new research from a clinical trial led by researchers at The University of Texas MD Anderson Cancer Center. The findings, released today, will be presented on...

2012-05-16 11:20:03

Cell surface protein blows potent cells' cover; targeted drug works in preclinical tests Breast cancer stem cells wear a cell surface protein that is part nametag and part bull's eye, identifying them as potent tumor-generating cells and flagging their vulnerability to a drug, researchers at The University of Texas MD Anderson Cancer Center report online in Journal of Clinical Investigation. "We've discovered a single marker for breast cancer stem cells and also found that it's...

2012-04-26 23:54:58

Researchers trace influence via mouse model that allows oncogene to be turned on and off A genetic mutation that drives the initiation of pancreatic cancer also manipulates metabolic pathways to support tumor growth and progression, scientists report in the journal Cell. This newly discovered role for the Kras oncogene opens up a new category of potential targets for thwarting the influential mutation, which has proved difficult to attack directly, said study co-lead author Haoqiang...

2012-04-02 09:09:21

Researchers control drug side effects for treatment gains in Phase I trial A pair of targeted therapies shrank tumors in some patients with treatment-resistant Ewing's sarcoma or desmoplastic small-round-cell tumors, according to research led by investigators from The University of Texas MD Anderson Cancer Center reported at the AACR Annual Meeting 2012. Five of 17 Ewing's sarcoma patients responded to the combination, with two achieving complete responses, one for 27 weeks. The...


Latest University of Texas Reference Libraries

0_fe943975ac9bf51fce9af054402a4655
2010-11-18 18:05:49

Michael Baker is an engineer and a retired United States Navy captain and NASA astronaut. He was born Michael Allen Baker on October 27, 1953 in Memphis, Tennessee, though he considers Lemoore, California to be his hometown. As a child he was active in the Boy Scouts of America. He graduated from Lemoore Union High School in 1971 and received a Bachelor of Science degree in aerospace engineering from the University of Texas in 1975. After his graduation, Baker completed flight training and...

More Articles (1 articles) »
Word of the Day
penuche
  • A fudgelike confection of brown sugar, cream or milk, and chopped nuts.
'Penuche' is a variant of 'panocha,' a coarse grade of sugar made in Mexico. 'Panocha' probably comes from the Spanish 'panoja, panocha,' ear of grain.
Related